MammoSite Brachytherapy Catheter Faces Reimbursement Difficulties
This article was originally published in The Gray Sheet
Executive Summary
Temporary codes denoting Proxima Therapeutics' MammoSite high-dose rate brachytherapy catheter are necessary to allow sufficient reimbursement of the technology under the hospital OPPS, according to the Pinnacle Health Group (PHG)